SGA
VIR icon

Sector Gamma AS’s Vir Biotechnology VIR Stock Holding History

Sector Gamma AS’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-148,538
Closed -$1.49M – 33
2023
Q4 		$1.49M Hold
148,538
– – 0.36% 30
2023
Q3 		$1.39M Sell
148,538
-1,868
-1% -$26.6K 0.36% 28
2023
Q2 		$3.69M Buy
150,406
+4,861
+3% +$122K 0.83% 28
2023
Q1 		$3.39M Buy
145,545
+55,737
+62% +$1.43M 0.82% 28
2022
Q4 		$2.27M Hold
89,808
– – 0.52% 30
2022
Q3 		$1.73M Sell
89,808
-20,415
-19% -$519K 0.45% 27
2022
Q2 		$2.81M Buy
110,223
+30,000
+37% +$700K 0.63% 30
2022
Q1 		$2.06M Buy
80,223
+36,223
+82% +$1.07M 0.45% 38
2021
Q4 		$1.84M Buy
+44,000
New +$1.72M 0.43% 33

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return